Free Trial

INSPECS Group (SPEC) Competitors

INSPECS Group logo
GBX 42.90 -0.70 (-1.60%)
As of 11:06 AM Eastern

SPEC vs. BVC, AKR, CNSL, ODX, CTEC, AMS, TSTL, CIR, BVXP, and 4BB

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Tristel (TSTL), Circassia Group (CIR), Bioventix (BVXP), and 4basebio (4BB). These companies are all part of the "medical" sector.

INSPECS Group vs. Its Competitors

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

In the previous week, BATM Advanced Communications had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. BATM Advanced Communications' average media sentiment score of 1.35 beat INSPECS Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
INSPECS Group Neutral

BATM Advanced Communications has a net margin of -0.21% compared to INSPECS Group's net margin of -2.10%. BATM Advanced Communications' return on equity of -0.22% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
INSPECS Group -2.10%-4.00%0.45%

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than INSPECS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£130.32M0.62-£278.26K-£0.04-355.19
INSPECS Group£195.14M0.22-£4.11M-£4.04-10.62

BATM Advanced Communications has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 6.5%. INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. INSPECS Group pays out -24.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

42.4% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 67.8% of INSPECS Group shares are owned by institutional investors. 26.2% of BATM Advanced Communications shares are owned by insiders. Comparatively, 25.6% of INSPECS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

BATM Advanced Communications beats INSPECS Group on 11 of the 15 factors compared between the two stocks.

Get INSPECS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£43.62M£3.42B£5.54B£3.02B
Dividend Yield2.00%1.99%3.75%5.02%
P/E Ratio-10.6218.8321.01165.88
Price / Sales0.22350.56433.81285,131.44
Price / Cash1.63146.5436.1627.97
Price / Book0.432.528.124.46
Net Income-£4.11M£99.80M£3.25B£5.90B
7 Day Performance-8.11%-2.29%0.97%3.82%
1 Month Performance-7.73%-1.48%7.36%9.81%
1 Year Performance-26.03%118.81%31.31%74.29%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
N/AGBX 42.90
-1.6%
N/A-22.8%£43.62M£195.14M-10.621,673
BVC
BATM Advanced Communications
N/AGBX 14.39
-8.3%
N/A-23.0%£76.42M£130.32M-334.07980Positive News
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 4
+3.9%
N/A+10.7%£9.52M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
2.8242 of 5 stars
GBX 242.80
+0.6%
GBX 309.25
+27.4%
-3.0%£6.17B£2.71B40.8910,000
AMS
Advanced Medical Solutions Group
2.9081 of 5 stars
GBX 200.71
+0.9%
GBX 287.50
+43.2%
-10.8%£433.38M£132.18M38.8910Positive News
Analyst Forecast
Gap Up
TSTL
Tristel
0.1579 of 5 stars
GBX 405
-0.7%
GBX 400
-1.2%
-10.5%£193.47M£42.24M29.64208Negative News
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,690
-1.3%
N/A-31.8%£140.86M£13.65M17.4012News Coverage
4BB
4basebio
1.7427 of 5 stars
GBX 1,000
flat
GBX 1,600
+60.0%
-31.4%£128.10M£311K-1,282.05101High Trading Volume

Related Companies and Tools


This page (LON:SPEC) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners